Pay in 4 interest-free payments of $6.72 Learn more
Ships within 48 hours · Estimated delivery Sep 5 - Sep 10
Dihexa was developed as a structurally modified analogue of angiotensin IV and retains key features of the parent scaffold while incorporating modifications designed to alter physicochemical and pharmacological properties
Its a synthetic analogue of growth hormone-releasing hormone (GHRH)
This three-part mechanism explains the single most reproducible finding in the entire GHRP literature: the synergy with GHRH
BDCMs with abundant surface groups (primary and secondary hydroxyl groups) and excellent electron transfer abilities enable BDCM/transition metal-based hybrid catalysts to generate transport/reaction interfaces, which increases the OER activity and stability while increasing exposure to metal active sites
US$ 24.51
US$ 29.88
US$ 27.47
US$ 21.52
